Barbara Burtness, MD is Professor of Medicine (Medical Oncology) at the Yale School of Medicine, Chief Translational Research Officer, and Associate Cancer Center Director for Translational Research at the Yale Cancer Center.
She serves as Co-Leader of the Developmental Therapeutics Program, Division Chief for Head and Neck/Sarcoma Oncology, and Director of the Yale Head and Neck Specialized Program of Research Excellence.
Dr. Burtness is internationally recognized for her research in head and neck cancer.
She leads the ECOG-ACRIN Head and Neck Therapeutics Committee, which conducts large multicenter trials in head and neck cancer, and chairs multicenter trials of targeted therapy and immunotherapy in head and neck cancer. Some of her important studies are KEYNOTE - 048, ECOG ACRIN 3311 etc.Her laboratory studies novel combinatorial therapies to target p53 mutated head and neck cancer.
She is the chair of the ECOG-ACRIN Task Force for the Advancement of Women and has work on Deiversity, Equity and Inclusion in Research